Polfa Tarchomin investment plans begin to pay off and set to improve

Warsaw-based pharmaceutical producer Polfa Tarchomin has announced plans to spend zl. 180 million on investments by 2005. The company began implementing a restructuring program last year and since then has recorded a zl. 2.8 million net profit, while in 2000 the company made a zl. 25 million loss. "Although our profit may not be impressive, the tendency is what is im portant. Our profit would be higher if we did not have to pay back a zl. 25.7 million investment loan," said Andrzej Kleszczewski, Polfa Tarchomin president. The new restructuring plan entails cutting costs, changing management methods, renegotiating delivery agreements and pulling out of non-profitable investments. According to Kleszczewski the new plan will also prepare Polfa Tarchomin for Poland' s eventual entry into the European Union (EU) market. The company wants to focus on four areas of pharmaceuticals, such as over the counter drugs (OTC) and heart medicine. (Rzeczpospolita, p. B4) M.T.K.